• Sign up
  • Login

Scheme Profile

DSP Healthcare Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
2,352
Inception Date
30-11-2018
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 100
  • 52 Week High / Low ()
  • 33.267 (23-Feb-2024) / 21.258 (26-Apr-2023)
  • Incremental Investment ()
  • 100
  • NAV ()
  • 32.22 ( 0.20) ( 0.64 %)
  • Benchmark
  • S&P BSE Healthcare TRI
  • Fund Manager
  • Chirag Dagli
  • Value of () 1,00,000 since inception
  • 3,22,160
  • Entry Load
  • Nil
  • Exit Load
  • 0.50% - If redeemed/switched out within 1 months from the date of allotment. Nil - If redeemed/switched out after 1 months from the date of allotment.
  • Expense Ratio (%)
  • 2.54
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 38.37 times
  • Portfolio P/B
  • 5.86 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.12

Risk Factors

  • Jenson's Alpha
  • 1.78
  • Standard Deviation
  • 4.29
  • Beta
  • 0.87
  • Sharpe
  • 0.86
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.48

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • S&P BSE Healthcare TRI
  • 10.49
  • 5.19
  • 28.15
  • 54.79
  • 15.42
  • 20.12
  • 13.35
  • -

Company Top 5 Holdings

  [ As on 31 Mar 2024 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceuticals Industries Ltd
  • Equity
  • 20,37,581
  • 14.04
  • Ipca Laboratories Ltd
  • Equity
  • 16,03,985
  • 8.44
  • Suven Pharmaceuticals Ltd
  • Equity
  • 28,93,505
  • 8.33
  • Cipla Ltd
  • Equity
  • 12,83,790
  • 8.17
  • Lupin Ltd
  • Equity
  • 10,92,554
  • 7.51

Sector Top 5 Holdings

  [ As on 31 Mar 2024 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 1,52,74,001
  • 82.92
  • Healthcare
  • 17,64,727
  • 14.44
  • Insurance
  • 2,41,413
  • 1.99
  • Retail
  • 1,92,078
  • 0.65

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 6.40 8.42 10.49 2.19 2,352.32
2023 35.15 31.12 38.35 18.10 2,023.00
2022 -7.27 -9.58 -11.31 2.80 1,228.09
2021 22.33 17.96 20.57 21.69 1,441.84
2020 76.83 65.84 62.19 15.60 1,043.27
2019 7.55 4.22 -3.06 13.79 243.42
2018 1.18 -2.00 -5.45 6.67 157.69

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Mar-2024 8.90 7.94 10.84 1.91 2,352.32
Dec-2023 12.76 11.42 11.01 10.27 2,023.00
Sep-2023 10.62 11.39 11.65 0.96 1,730.06
Jun-2023 14.82 15.61 17.79 9.49 1,369.52

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Quick links

Close